Multicentre dose range study of a yeast-derived hepatitis B vaccine
- 1 September 1987
- Vol. 5 (3) , 179-183
- https://doi.org/10.1016/0264-410x(87)90096-x
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- BOOSTING PROPERTIES OF RECOMBINANT DNA HEPATITIS B VACCINEThe Lancet, 1986
- Dose range study in healthy volunteers of a hepatitis B vaccine produced in yeastAntiviral Research, 1985
- IMMUNOGENICITY OF RECOMBINANT YEAST HEPATITIS B VACCINEThe Lancet, 1985
- CLINICAL EVALUATION OF A RECOMBINANT HEPATITIS B VACCINEThe Lancet, 1984
- Clinical Evaluation in Healthy Adults of a Hepatitis B Vaccine Made by Recombinant DNAJAMA, 1984
- EFFICACY OF HEAT-INACTIVATED HEPATITIS B VACCINE IN HAEMODIALYSIS PATIENTS AND STAFFThe Lancet, 1983